Dialysis access justice, equity, diversity, inclusion (DA-jedi) program

Active Project Grant Awarded Last action

Award ID
R25DK136141
Recipient
Awarding agency
Obligated
$315,563

Award facts

Completion date 57% complete
Originally
Place of performance
Washington, DC 20005, USA

Award details come from USAspending.gov.

Description

Abstract
ASN is the largest nephrology society in the world with more than 21,000 members and a longstanding commitment to justice, equity, diversity, and inclusion. Within kidney disease there is a great need for equity in dialysis access (DA). We plan to significantly expand our DEI footprint in this area through the dialysis access- justice, equity, diversity and inclusion program (DA-jedi) by recruiting a cohort of fellows/early-career faculty who identify as underrepresented in medicine (URM). These individuals would then be exposed to a unique blend of mentorship, leadership, and skill development courses, with a strong DA focus, that will set them on a pathway to become champions for equitable, patient-centered DA care, and also future leaders in ASN and the broader dialysis access and kidney community. We will achieve these goals through four specific aims. In specific aim 1 we will recruit a cohort of participants who identify as URM into DA-jedi. In specific aim 2 we will provide individualized didactic and experiential skills training through ASN initiatives, through the participants ctsa, or though DA-jedi's own ctsa links. This will include an annual DA-jedi symposium. In specific aim 3, we will foster unique multi-faceted mentorship opportunities, and finally in specific aim 4 we will focus on the creation of an alumni network, promote networking opportunities and develop an interactive evaluation process with a strong feedback loop. Putting IT all together, we strongly believe that growing our DA-jedi participants into future leaders for ASN, the kidney community, and the DA community, will allow US to better serve our patients, who deserve justice, equity, diversity, and inclusion in both DA and kidney care.

Transactions

Action Obligated Date
Amendment $111,510
Amendment $111,510
Amendment $111,510
Amendment Fostering innovative leaders in nephrology and dialysis (find) - to better reflect the evolution of this project as a leadership development program, the… $43,492
Amendment $0
Amendment $0
Amendment Fostering innovative leaders in nephrology and dialysis (find) - to better reflect the evolution of this project as a leadership development program, the… $0
Amendment -$43,492
Amendment -$111,510
Amendment -$111,510
Amendment -$155,002
Amendment -$155,002
Amendment -$155,002
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $111,510
Amendment $111,510
Amendment $111,510
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $111,510
Amendment $111,510
Original award $111,510
Show all 28

Quick answers

Who received award R25DK136141?

R25DK136141 was awarded to American Society Of Nephrology Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 1, 2023.

How much is award R25DK136141 worth?

$315,563 has been obligated on R25DK136141.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award